- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07767734
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education
August 11, 2026 updated by: Liang Qi, Jiangsu Medical College
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education for Pharmacy Students
This study aims to compare the teaching effect of the BOPPPS teaching model and the traditional lecture-based teaching method in Medicinal Chemistry courses for pharmacy students.
Two groups of students receiving different teaching strategies will be included in this retrospective controlled study.
The primary evaluation indicators include students' final examination scores, and secondary indicators cover classroom learning engagement and student satisfaction questionnaires.
The overall objective is to explore whether the BOPPPS model can improve students' learning performance and learning experience in Medicinal Chemistry teaching.
No human clinical intervention or invasive testing is involved in this educational research.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This educational controlled study focuses on the teaching reform of Medicinal Chemistry, a core compulsory course for pharmacy majors in higher vocational colleges.
Traditional lecture-centered teaching is widely adopted in vocational pharmacy teaching, which often leads to insufficient student participation, weak initiative in classroom interaction, and unsatisfactory learning efficiency for complex pharmaceutical chemical structures and synthetic reactions.The BOPPPS teaching model divides each class into six standardized links: Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment, Summary.
This student-centered teaching design strengthens classroom interaction and targeted detection of learning effects.
At present, there is limited comparative research on the application of this model in Medicinal Chemistry teaching for vocational pharmacy students.This retrospective controlled research collects historical teaching data of two student groups receiving different teaching modes.
The research intends to systematically analyze the differences in learning outcomes between the two teaching strategies, so as to provide practical teaching reform references for Medicinal Chemistry courses in vocational pharmacy education.
This study only adopts routine classroom teaching and anonymous questionnaire surveys, without any clinical medical intervention, blood sampling or physical examination on participants.
All student data are anonymized to protect personal privacy.
Article 32 of the Notice on Printing and Distributing the Measures for Ethical Review of Life Science and Medical Research Involving Humans, jointly issued by the National Health Commission of China, the Ministry of Education, the Ministry of Science and Technology, and the National Administration of Traditional Chinese Medicine, stipulates that "Life science and medical research involving humans that uses human information, data or biological samples may be exempt from ethical review if such research falls under the circumstances specified below, causes no physical harm to human participants, and does not involve sensitive personal information or commercial interests."
As a study focusing on teaching effectiveness, the present research qualifies for an exemption from ethical review pursuant to this provision.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Yancheng, Jiangsu, China, 224005
- Jiangsu Medical College
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Full-time pharmacy students without previous Medicinal Chemistry learning experience
- Complete all academic assessments and anonymous questionnaire surveys
Exclusion Criteria:
- Classroom attendance rate less than 80%
- Students who are unwilling to provide relevant data for this educational study or miss the final exam
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group (BOPPPS Teaching Model)
Pharmacy students receive Medicinal Chemistry courses adopting the complete six-link BOPPPS teaching design, including Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary.
Interactive classroom activities and in-class tests are arranged in each lesson.
|
Medicinal Chemistry teaching based on BOPPPS model, consisting of Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary sessions with abundant classroom interaction.
|
|
Active Comparator: Control Group (Traditional Lecture Teaching)
Pharmacy students receive teacher-centered traditional lecture-based Medicinal Chemistry teaching.
The teacher explains knowledge points directly, with few classroom interactive sessions.
|
Traditional teacher-centered lecture teaching for Medicinal Chemistry, mainly knowledge explanation, without segmented pre-assessment and post-assessment arrangements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Final examination scores of Medicinal Chemistry
Time Frame: At the completion of the teaching intervention, up to 1 week
|
Final exam scores to evaluate students' mastery of professional knowledge of Medicinal Chemistry.
Scores range from 0 to 100.
Higher scores indicate better academic performance.
|
At the completion of the teaching intervention, up to 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Student teaching satisfaction score
Time Frame: At the completion of the teaching intervention, up to 1 week
|
Score from an anonymous questionnaire evaluating students' satisfaction with the classroom teaching model.
The total score ranges from 1 to 5. Higher scores indicate higher satisfaction.
|
At the completion of the teaching intervention, up to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Liang Qi, PhD, Jiangsu Medical College
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2025
Primary Completion (Actual)
January 6, 2026
Study Completion (Actual)
January 8, 2026
Study Registration Dates
First Submitted
August 6, 2026
First Submitted That Met QC Criteria
August 11, 2026
First Posted (Actual)
August 17, 2026
Study Record Updates
Last Update Posted (Actual)
August 17, 2026
Last Update Submitted That Met QC Criteria
August 11, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- JiangsuMC-20260806
- 2025JGYB272 (Other Grant/Funding Number: Jiangsu Society of Higher Education)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant-level data supporting this study, together with a complete data dictionary, will be accessible to qualified external researchers upon reasonable written request after the primary manuscript is published.
Data release is conditional on institutional and regulatory privacy authorization.
All formal data access requests should be submitted to the corresponding author for evaluation and review.
No identifiable personal information will be included in shared datasets to protect student privacy.
IPD Sharing Time Frame
De-identified individual participant data and supporting documents will be available to qualified researchers indefinitely after the publication of the primary study manuscript.
IPD Sharing Access Criteria
Data and supporting documents are available only to qualified academic researchers with legitimate educational research objectives.
All applicants shall submit a formal written research request to the corresponding author.
Data release is subject to institutional privacy and regulatory authorization.
Applicants must provide a clear research plan and agree to use the shared de-identified data solely for independent academic research, without attempting to re-identify participants or share datasets with third parties.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.